Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
NIO (NIO US)
Watchlist
794
Analysis
Consumer Discretionary
•
China
NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
02 Feb 2024 08:56
•
Broker
China Auto Sector – Jan NEV Sales in Line; More Catalysts After CNY
Eleven Chinese automakers including BYD, Great Wall, NIO, Xpeng, Li Auto, Zeekr, Aion, Deepal, Neta, Leap and Aito reported their Jan 2024 sales...
CMB International
Follow
475 Views
Share
bullish
•
Thematic (Sector/Industry)
•
30 Jan 2024 15:49
[Blue Lotus Daily]:ACMR/300750 SZ/DIDI/NIO/1810 HK/TCOM/LKNCY/2269 HK
Samsung Galaxy S24 pre-orders in South Korea reach nearly 1.2 million units; Luckin Coffee reduces registered capital by US$400mn; US Congress...
Blue Lotus Research Institute
Follow
241 Views
Share
bullish
•
Thematic (Sector/Industry)
•
26 Jan 2024 16:52
[Blue Lotus Daily]: ATAT/HTHT/TCOM/300750CH/1211HK/835185CH/ 600516CH/LI/NIO/XPEV/BEKE/ZTO
Sungrow's full-year profit exceeds expectations; Li Auto's deliveries improve but fall short; Chongqing raises property tax levy standard.
Blue Lotus Research Institute
Follow
475 Views
Share
bullish
•
Thematic (Sector/Industry)
•
26 Jan 2024 06:49
•
Broker
China Auto Sector – Attractive valuation with likely resilient earnings
According to insurance data, China’s passenger-vehicle (PV) retail sales volume rose 0.3% YoY and 28% MoM to 2.53mn units in Dec 2023, 6% higher...
CMB International
Follow
524 Views
Share
bullish
•
Thematic (Sector/Industry)
•
19 Jan 2024 14:14
[Blue Lotus Daily]: 1211HK/XPEV/NIO/9995HK/TCOM/1024HK/780HK/3690HK
Xpeng and NIO's weekly sales weaken; RemeGen's ADC to Pfizer rumors may be returned; Ctrip partners with Kuaishou to boost travel products.
Blue Lotus Research Institute
Follow
478 Views
Share
First
Previous
24
25
26
27
28
29
30
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x